The Fed cut rates to 3.50-3.75% from a 5.25-5.50% peak, but Series A multiples are still stuck at 8-15x ARR versus 20-30x in 2021. That's the short answer. The longer answer is that rate cuts fixed the cost of capital but not the risk appetite, capital-efficiency bar, or exit math that actually set valuations during the 2021 boom.
Founders and even a lot of investors keep waiting for a rate-cut-driven return to 2021 pricing. It isn't coming, and the 2026 data explains exactly why: cheaper money changed deal volume and discount rates, but it never reset the growth-at-all-costs underwriting standard that made 20-30x multiples normal five years ago.
Figures blended from the Federal Reserve, Bureau of Labor Statistics CPI data, Carta, PitchBook, and Yanne Capital's 2026 down-round data.
How rising and falling interest rates changed startup valuations since 2021
Interest rates moved from near-zero in 2021 to a 5.25-5.50% peak in 2023 as the Fed fought inflation, then eased back down to 3.50-3.75% by late 2025 — where they've held through mid-2026. Startup valuations followed a similar arc but with a lag and a much less complete recovery: Series A multiples cratered from 20-30x ARR in 2021 to 3-5x at the 2023 trough, and have only partially rebounded to 8-15x in 2026 even though rates have fallen more than 150 basis points from their peak.
The mechanism is straightforward in theory: lower rates reduce the discount rate applied to a startup's future cash flows, which mechanically supports higher present-value multiples, and they also push capital out of safe money-market yields and into riskier venture bets. In practice, the 2026 numbers show that mechanism only did part of the work — the rest of the multiple compression from 2021 was about risk appetite and underwriting discipline, not the cost of capital, and that part hasn't reversed.
Why the Fed's 2026 rate-cut cycle only partially fixed valuations
Three things are keeping multiples well below 2021 levels even with cheaper capital available. First, inflation is running hot again — May 2026 CPI came in at 4.2% year-over-year and core PCE at 3.4%, both well above the Fed's 2% target, which is why futures markets in early July priced roughly 75% odds the Fed holds steady rather than cutting further, with a real minority pricing a hike instead. That inflation backdrop caps how much further capital gets cheaper from here.
Second, LPs rewired what they demand from GPs. LPs now screen funds on DPI — cash actually distributed — rather than paper TVPI, which forces GPs to underwrite for real exits and profitability rather than markup momentum. That discipline flows straight through to how GPs price term sheets: capital efficiency and unit economics now dominate the diligence conversation in a way "growth at all costs" never had to survive in 2021.
Third, the exit market itself is still thin relative to 2021's pace, even with the 2026 IPO window reopening for select names. Fewer realized outcomes means less proof that a 20-30x entry multiple ever pays off, so investors underwrite to a lower multiple as a risk buffer regardless of what the Fed funds rate happens to be that quarter.
Startup valuation multiples in 2026 vs the 2021 peak and 2023 trough
The table below lines up the key metrics across all three periods, since the 2026 numbers only make sense in the context of how far they fell and how much they've recovered.
| Metric | 2021 peak | 2023 trough | 2026 |
|---|---|---|---|
| Fed funds rate | 0.00-0.25% | 5.25-5.50% | 3.50-3.75% |
| Series A revenue multiple | 20-30x ARR | 3-5x ARR | 8-15x ARR |
| Series A pre-money (median) | $55-65M | $25-30M | $35-45M |
| Down rounds, growth-stage | ~4% | rising sharply | 24% (H1 2025) |
| Global VC funding (annual) | $681B | $304B | ~$314-330B |
| Growth-stage forward multiple | ~50x forward ARR | compressed sharply | ~8x forward ARR |
| Dominant investor priority | Growth at all costs | Survival, runway | Capital efficiency, DPI |
Figures are 2026 estimates blended from PitchBook, Carta, the Federal Reserve, and Yanne Capital's H2 2026 down-round data. Series A and growth-stage multiples reflect high-growth companies specifically, not the full market average.
The AI premium is masking how weak non-AI valuations still are
Aggregate 2026 valuation data hides a sharp bifurcation: AI-native startups with genuine technical capability are commanding 30-50% valuation premiums over otherwise comparable non-AI companies, and that premium is doing a lot of the work in pulling the blended Series A multiple up to 8-15x. A profitable, capital-efficient SaaS company without an AI story is often still pricing closer to the 2023 trough than to the 2026 blended average.
That split shows up clearly in SaaS valuation data we track: net revenue retention and gross margin now matter more to a non-AI company's multiple than the overall interest-rate environment, because investors have effectively decided AI exposure is the one factor still worth paying a growth premium for, rate cuts or not.
Why 24% of growth-stage deals are still down rounds despite lower rates
Down rounds hit 24% of US growth-stage financings in H1 2025, up sixfold from roughly 4% in 2021, and that figure hasn't meaningfully improved as rates have eased. The reason is structural rather than cyclical: a company that raised its last round at a 2021-vintage 20-30x multiple has to reset to today's 8-15x reality no matter what the Fed funds rate is this quarter, because the prior valuation was never supported by anything except that era's risk appetite.
Rate cuts help new, first-time financings get priced more generously than they would have at 5.25-5.50%, but they do nothing to retroactively repair a cap table anchored to a valuation set during a fundamentally different market. That's why founders who raised in 2021 are still working through down rounds, bridge rounds, and recapitalizations in 2026 even as the broader rate environment has become more favorable.
What would it take for interest rates to lift startup valuations back to 2021 levels?
Getting back to 2021-style startup valuations would require more than another round of Fed cuts — it would take the Fed funds rate returning to something close to zero, inflation cooling well below the current 4.2% CPI print, and the exit market reopening wide enough to prove out today's already-lower multiples with real DPI. None of those three conditions look close in July 2026: futures markets are pricing roughly 75% odds of a hold at 3.50-3.75%, and a meaningful minority is pricing a hike, not a cut.
Even if the Fed did cut aggressively from here, the LP-side discipline described above is a structural change, not a rate-driven one. LPs who lived through the 14-15% DPI drought since late 2022 are unlikely to go back to underwriting on TVPI markups alone just because capital gets cheaper again — which means even a return to near-zero rates probably compresses the gap to 2021 pricing without fully closing it.
The more realistic path is the one already playing out: multiples drift up gradually as exits accumulate and prove out current pricing, AI-native companies keep commanding their 30-50% premium, and non-AI companies compete on capital efficiency rather than growth rate. That's a slower, more selective recovery than founders who raised in 2021 are hoping for.
What founders and investors should actually do about it
For founders raising in this environment, the practical takeaway is to underwrite your own round to today's 8-15x reality rather than anchor expectations to a 2021 comp or a prior round's price — and to build a growth story around efficient revenue and gross margin, not just top-line velocity, since that's what's actually driving the premium multiples in 2026. If your last round was priced in 2021, plan for a down round or a structured bridge rather than assuming rate cuts will bail out the old valuation.
For investors, the framework is the same one reshaping VC fund performance more broadly: price to DPI and realistic exit multiples, not to the hope that the next rate-cut cycle reflates 2021 comps. The funds still underwriting deals as if a few more Fed cuts will get them back to 20-30x ARR are the ones most likely to be marking down portfolios again in the next cycle.
Bottom line: Interest rates falling from a 5.25-5.50% peak to 3.50-3.75% helped, but they didn't come close to fully restoring 2021-era startup valuations. Series A multiples sit at 8-15x ARR versus 20-30x five years ago, down rounds are still running at 24% of growth-stage deals, and the entire recovery is propped up by a 30-50% AI premium that non-AI companies don't get. If you're modeling a 2021-style re-rating on the back of further Fed cuts, the 2026 data says that's the wrong trade — the underwriting standard changed permanently, and cheaper capital alone won't undo it.
Get VC data most people never see — free.
Weekly benchmarks, valuations, and fund data. No spam, unsubscribe anytime.